-- 
Pharmasset Hepatitis C Drug Combination Helped 98% of Patients

-- B y   N a o m i   K r e s g e
-- 
2011-03-31T12:30:00Z

-- http://www.bloomberg.com/news/2011-03-31/pharmasset-hepatitis-c-drug-combination-helped-98-of-patients.html
Pharmasset Inc. (VRUS) â€™s experimental
hepatitis C drug PSI-7977 was effective when added to standard
therapy in 98 percent of patients in a 121-person clinical
trial, researchers said at the European Association for the
Study of the Liver conference today in Berlin.  To contact the reporter on this story:
Naomi Kresge in Berlin at 
 nkresge@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at   pserafino@bloomberg.net  